SCHEMBL18197876

SCHEMBL18197876

c1cnn2c(Cc3ccc4sccc4c3)nnc2c1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MET P08581 18/20 0.44
CYP2A6 P11509 1/20 0.42
PDE10A Q9Y233 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2495818 0.77 MET (0.67) MET
SCHEMBL19338390 0.74 MET (0.63) MET
SCHEMBL18197862 0.73 MET (0.60) MET
SCHEMBL18197881 0.71 MET (0.55) MET
SCHEMBL18197850 0.71 MET (0.46) MET
SCHEMBL19338425 0.70 MET (0.49) MET
SCHEMBL1659800 0.69 MET (0.43) MET
SCHEMBL10838270 0.69 CYP2A6 (0.50) CYP2A6PDE10A
SCHEMBL19338408 0.69 MET (0.35) MET
SCHEMBL18197888 0.68 MET (0.41) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966214-B9 TRIAZOLOPYRIDAZINES AS TYROSINE KINASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-09-13 EP disclosed
EP-1966214-B1 TRIAZOLOPYRIDAZINES AS TYROSINE KINASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-11-02 EP disclosed